Reactive perforating collagenosis: a condition that may be underdiagnosed.
Reactive perforating collagenosis is a perforating disorder developing in adults, usually in association with diabetes mellitus or renal failure. We present three cases diagnosed at the Royal Prince Alfred Hospital in a 5 month period. All three patients had long-standing diabetes mellitus, hypertension, hypercholesterolaemia and ischaemic heart disease. Each patient presented with generalized pruritus and a papular eruption across the trunk and limbs. More than one biopsy or multiple levels were needed before the diagnostic histological features were seen. The first patient responded to 0.5% phenol with 10% glycerine in sorbolene cream. The second patient did not respond to topical betamethasone diproprionate 0.5 mg/g cream and antihistamines (hydroxyzine 25 mg nocte) and required narrow-band ultraviolet (UV) B. The third patient, having failed to respond to topical betamethasone diproprionate 0.5 mg/g cream and wet dressings, antihistamines (hydroxyzine 25 mg tds and doxepin 50 mg nocte) and UVB required acitretin 25 mg orally per day. Because reactive perforating collagenosis responds to treatment, we believe this condition should be considered in patients with diabetes mellitus or renal failure presenting with pruritus and that biopsy of intact lesions may need multiple levels to help establish the diagnosis.
Satchell
A C
AC
Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Crotty
K
K
Lee
S
S
D017255:Acitretin / Q000627:therapeutic use; D000284:Administration, Oral; D000287:Administration, Topical; D000368:Aged; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D001706:Biopsy; D003095:Collagen Diseases / Q000473:pathology* / Q000628:therapy; D048909:Diabetes Complications; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use; D008875:Middle Aged; D019800:Phenol / Q000627:therapeutic use; D051437:Renal Insufficiency / Q000150:complications; D014467:Ultraviolet Therapy / Q000379:methods
D000891:Anti-Infective Agents, Local; D007641:Keratolytic Agents; D019800:Phenol; D017255:Acitretin